Is Bombay Super Hyb overvalued or undervalued?

As of 25 September 2025, the valuation grade for Bombay Super Hyb has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 51.63, an EV to EBITDA ratio of 43.91, and a PEG ratio of 2.41, all of which suggest a high valuation relative to earnings and growth potential.
In comparison to peers, Jain Irrigation has a PE ratio of 114.26 and an EV to EBITDA of 10.50, while Indo US Bio-Tech is valued more reasonably with a PE of 15.55 and an EV to EBITDA of 14.07. These comparisons highlight that Bombay Super Hyb's valuation metrics are significantly higher than those of its peers, reinforcing the conclusion that it is overvalued. Additionally, while the company's stock has outperformed the Sensex over the long term, recent performance shows a decline of 12.45% year-to-date compared to a 5.27% increase in the Sensex, further supporting the overvaluation narrative.